09:51 AM EST - Avai Bio Inc : Together with joint venture partner Austrianova, today announced that Prof. Walter H. Günzburg presented the companies’ encapsulated-cell approach to sustained a-Klotho delivery at the Second Annual Klotho Conference, held September 18–19 in Miami. The 20-minute talk outlined how Austrianova’s Cell-in-a-Box® technology is being applied through Klothonova, the 50/50 joint venture formed by Avaí Bio and Austrianova in 2025, to develop implanted, encapsulated cells designed for long-term production of a-Klotho. Avai Bio Inc
shares O.AVAI are trading unchanged at $0.12.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=AVAI&qmodStoryID=7101512815019644
